LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 83

Search options

  1. Article ; Online: High-density lipoprotein cholesterol efflux capacity in patients with obstructive sleep apnea and its relation with disease severity.

    Fadaei, Reza / Mohassel Azadi, Samaneh / Rhéaume, Eric / Khazaie, Habibolah

    Lipids in health and disease

    2022  Volume 21, Issue 1, Page(s) 116

    Abstract: Background: Obstructive sleep apnea (OSA) is linked to an accelerated risk of cardiovascular disease (CVD). Some key CVD risk factors are present in patients suffering from OSA such as hypertension, inflammation, oxidative stress, and dyslipidemia. High- ...

    Abstract Background: Obstructive sleep apnea (OSA) is linked to an accelerated risk of cardiovascular disease (CVD). Some key CVD risk factors are present in patients suffering from OSA such as hypertension, inflammation, oxidative stress, and dyslipidemia. High-density lipoprotein (HDL) cholesterol efflux capacity (CEC) is proposed as a reliable biomarker of HDL function and the present study aimed to quantify this biomarker in patients with OSA.
    Methods: ATP binding cassette subfamily A member 1 (ABCA1), non-ABCA1, and total CEC were determined in 69 polysomnographic-confirmed OSA patients and 23 controls. Moreover, paraoxonase (PON) activities, high-sensitivity C-reactive protein (hsCRP), apolipoprotein B (apo B), and apolipoprotein A-I (apo A-I) circulating levels were quantified in the studied population.
    Results: All CEC measures were reduced in the OSA group compared to the control group. Strikingly, ABCA1 CEC was diminished in severe OSA in comparison with mild OSA. Furthermore, PON activities and apo A-I showed lower levels, while hsCRP and apo B were elevated in OSA patients compared to controls. Moreover, ABCA1 CEC showed an inverse association with hsCRP and a positive association with apo A-I, while non-ABCA1 CEC presented an association with HDL-C.
    Conclusion: These results suggest the presence of an impaired HDL function in OSA. In particular, ABCA1 CEC was associated with disease severity and inflammation which could be a factor increasing the risk of CVD.
    MeSH term(s) Humans ; Cholesterol, HDL/metabolism ; Apolipoprotein A-I/metabolism ; C-Reactive Protein/metabolism ; ATP Binding Cassette Transporter 1/genetics ; ATP Binding Cassette Transporter 1/metabolism ; Cardiovascular Diseases/etiology ; Biomarkers ; Inflammation/complications ; Sleep Apnea, Obstructive/genetics ; Sleep Apnea, Obstructive/complications ; Severity of Illness Index ; Apolipoproteins B
    Chemical Substances Cholesterol, HDL ; Apolipoprotein A-I ; C-Reactive Protein (9007-41-4) ; ATP Binding Cassette Transporter 1 ; Biomarkers ; Apolipoproteins B
    Language English
    Publishing date 2022-11-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 2091381-3
    ISSN 1476-511X ; 1476-511X
    ISSN (online) 1476-511X
    ISSN 1476-511X
    DOI 10.1186/s12944-022-01723-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Single Functional Group Platform for Multistimuli Responsivities: Tertiary Amine for CO

    Yong, Hui Wen / Ferron, Marine / Mecteau, Mélanie / Mihalache-Avram, Teodora / Lévesque, Sylvie / Rhéaume, Éric / Tardif, Jean-Claude / Kakkar, Ashok

    Biomacromolecules

    2023  Volume 24, Issue 9, Page(s) 4064–4077

    Abstract: The design of multistimuli-responsive soft nanoparticles (NPs) often presents synthetic complexities and limited breadth in exploiting changes surrounding physiological environments. Nanocarriers that could collectively take advantage of several ... ...

    Abstract The design of multistimuli-responsive soft nanoparticles (NPs) often presents synthetic complexities and limited breadth in exploiting changes surrounding physiological environments. Nanocarriers that could collectively take advantage of several endogenous stimuli can offer a powerful tool in nanomedicine. Herein, we have capitalized on the chemical versatility of a single tertiary amine to construct miktoarm polymer-based nanocarriers that respond to dissolved CO
    MeSH term(s) Carbon Dioxide ; Reactive Oxygen Species ; Macrophages ; Curcumin/pharmacology ; Hydrogen-Ion Concentration
    Chemical Substances Carbon Dioxide (142M471B3J) ; Reactive Oxygen Species ; Curcumin (IT942ZTH98)
    Language English
    Publishing date 2023-08-30
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1526-4602
    ISSN (online) 1526-4602
    DOI 10.1021/acs.biomac.3c00434
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Time to study another variant of endothelial progenitor cells?

    Rhéaume, Eric

    Cardiovascular research

    2010  Volume 88, Issue 1, Page(s) 3–4

    MeSH term(s) Animals ; Aorta/immunology ; Aorta/transplantation ; Cell Differentiation ; Cell Proliferation ; Cell Survival ; Complement Activation ; Cytotoxicity, Immunologic ; Endothelial Cells/immunology ; Endothelial Cells/transplantation ; Graft Survival ; Histocompatibility Antigens/immunology ; Immunity, Cellular ; Immunity, Humoral ; Interferon-gamma/immunology ; Phenotype ; Rats ; Stem Cell Transplantation ; T-Lymphocytes/immunology ; Transplantation, Homologous
    Chemical Substances Histocompatibility Antigens ; Interferon-gamma (82115-62-6)
    Language English
    Publishing date 2010-10-01
    Publishing country England
    Document type Comment ; Editorial
    ZDB-ID 80340-6
    ISSN 1755-3245 ; 0008-6363
    ISSN (online) 1755-3245
    ISSN 0008-6363
    DOI 10.1093/cvr/cvq216
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Significance of the Wnt signaling pathway in coronary artery atherosclerosis.

    Khan, Kashif / Yu, Bin / Tardif, Jean-Claude / Rhéaume, Eric / Al-Kindi, Hamood / Filimon, Sabin / Pop, Cristina / Genest, Jacques / Cecere, Renzo / Schwertani, Adel

    Frontiers in cardiovascular medicine

    2024  Volume 11, Page(s) 1360380

    Abstract: Introduction: The progression of coronary atherosclerosis is an active and regulated process. The Wnt signaling pathway is thought to play an active role in the pathogenesis of several cardiovascular diseases; however, a better understanding of this ... ...

    Abstract Introduction: The progression of coronary atherosclerosis is an active and regulated process. The Wnt signaling pathway is thought to play an active role in the pathogenesis of several cardiovascular diseases; however, a better understanding of this system in atherosclerosis is yet to be unraveled.
    Methods: In this study, real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting were used to quantify the expression of Wnt3a, Wnt5a, and Wnt5b in the human coronary plaque, and immunohistochemistry was used to identify sites of local expression. To determine the pathologic significance of increased Wnt, human vascular smooth muscle cells (vSMCs) were treated with Wnt3a, Wnt5a, and Wnt5b recombinant proteins and assessed for changes in cell differentiation and function.
    Results: RT-PCR and Western blotting showed a significant increase in the expression of Wnt3a, Wnt5a, Wnt5b, and their receptors in diseased coronary arteries compared with that in non-diseased coronary arteries. Immunohistochemistry revealed an abundant expression of Wnt3a and Wnt5b in diseased coronary arteries, which contrasted with little or no signals in normal coronary arteries. Immunostaining of Wnt3a and Wnt5b was found largely in inflammatory cells and myointimal cells. The treatment of vSMCs with Wnt3a, Wnt5a, and Wnt5b resulted in increased vSMC differentiation, migration, calcification, oxidative stress, and impaired cholesterol handling.
    Conclusions: This study demonstrates the upregulation of three important members of canonical and non-canonical Wnt signaling pathways and their receptors in coronary atherosclerosis and shows an important role for these molecules in plaque development through increased cellular remodeling and impaired cholesterol handling.
    Language English
    Publishing date 2024-03-22
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2781496-8
    ISSN 2297-055X
    ISSN 2297-055X
    DOI 10.3389/fcvm.2024.1360380
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Lipoprotein (a), arterial inflammation, and PCSK9 inhibition.

    Tardif, Jean-Claude / Rhéaume, Eric / Rhainds, David / Dubé, Marie-Pierre

    European heart journal

    2019  Volume 40, Issue 33, Page(s) 2782–2784

    MeSH term(s) Arteritis ; Humans ; Inflammation ; Lipoprotein(a) ; Proprotein Convertase 9 ; Subtilisins
    Chemical Substances Lipoprotein(a) ; PCSK9 protein, human (EC 3.4.21.-) ; Proprotein Convertase 9 (EC 3.4.21.-) ; Subtilisins (EC 3.4.21.-)
    Language English
    Publishing date 2019-03-05
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehz087
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Adcy9 Gene Inactivation Improves Cardiac Function After Myocardial Infarction in Mice.

    Ferron, Marine / Merlet, Nolwenn / Mihalache-Avram, Teodora / Mecteau, Mélanie / Brand, Geneviève / Gillis, Marc-Antoine / Shi, Yanfen / Nozza, Anna / Cossette, Mariève / Guertin, Marie-Claude / Rhéaume, Eric / Tardif, Jean-Claude

    The Canadian journal of cardiology

    2023  Volume 39, Issue 7, Page(s) 952–962

    Abstract: Background: Polymorphisms in the adenylate cyclase 9 (ADCY9) gene influence the benefits of the cholesteryl ester transfer protein (CETP) modulator dalcetrapib on cardiovascular events after acute coronary syndrome. We hypothesized that Adcy9 ... ...

    Abstract Background: Polymorphisms in the adenylate cyclase 9 (ADCY9) gene influence the benefits of the cholesteryl ester transfer protein (CETP) modulator dalcetrapib on cardiovascular events after acute coronary syndrome. We hypothesized that Adcy9 inactivation could improve cardiac function and remodelling following myocardial infarction (MI) in absence of CETP activity.
    Methods: Wild-type (WT) and Adcy9-inactivated (Adcy9
    Results: All mice developed LV hypertrophy, dilation, and systolic dysfunction, but Adcy9
    Conclusions: Adcy9 inactivation reduced infarct size, pathologic remodelling, and cardiac dysfunction. These changes were accompanied by preserved myocardial capillary density and increased adaptive immune response. Most of the benefits of Adcy9 inactivation were only observed in the absence of CETP.
    MeSH term(s) Animals ; Humans ; Male ; Mice ; Adenylyl Cyclases/genetics ; Adenylyl Cyclases/metabolism ; Myocardial Infarction/complications ; Myocardium/pathology ; Myocytes, Cardiac/metabolism ; Ventricular Remodeling/physiology
    Chemical Substances adenylate cyclase 9 (EC 4.6.1.1) ; Adenylyl Cyclases (EC 4.6.1.1) ; CETP protein, human
    Language English
    Publishing date 2023-04-11
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 632813-1
    ISSN 1916-7075 ; 0828-282X
    ISSN (online) 1916-7075
    ISSN 0828-282X
    DOI 10.1016/j.cjca.2023.04.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Associations of insulin-like growth factor binding protein-2 with metabolic profile and hepatic fat deposition in asymptomatic men and women.

    Rauzier, Chloé / Chartrand, Dominic J / Alméras, Natalie / Lemieux, Isabelle / Larose, Eric / Mathieu, Patrick / Pibarot, Philippe / Lamarche, Benoît / Rhéaume, Caroline / Poirier, Paul / Després, Jean-Pierre / Picard, Frédéric

    American journal of physiology. Endocrinology and metabolism

    2023  Volume 325, Issue 1, Page(s) E99–E105

    Abstract: Low circulating levels of insulin-like growth-factor binding protein-2 (IGFBP-2) have been associated with increased adiposity and metabolic alterations such as insulin resistance, dyslipidemia, and nonalcoholic fatty liver disease in individuals with ... ...

    Abstract Low circulating levels of insulin-like growth-factor binding protein-2 (IGFBP-2) have been associated with increased adiposity and metabolic alterations such as insulin resistance, dyslipidemia, and nonalcoholic fatty liver disease in individuals with obesity. However, whether IGFBP-2 affects energy metabolism in the early stages of these disorders remains unclear. Herein, we hypothesized that plasma IGFBP-2 concentrations are inversely associated with early liver fat accumulation and alterations in lipid and glucose homeostasis in apparently healthy and asymptomatic men and women. Three hundred thirty-three middle-aged Caucasian men and women apparently healthy and without cardiovascular symptoms were enrolled for a cross-sectional cardiometabolic imaging study. Individuals with BMI ≥ 40 kg/m
    MeSH term(s) Male ; Middle Aged ; Humans ; Female ; Insulin Resistance ; Insulin-Like Growth Factor Binding Protein 2/metabolism ; Cross-Sectional Studies ; Obesity/metabolism ; Triglycerides/metabolism ; Liver/diagnostic imaging ; Liver/metabolism ; Hypercholesterolemia/metabolism ; Cardiovascular Diseases/metabolism ; Glucose/metabolism ; Metabolome ; Intra-Abdominal Fat/metabolism
    Chemical Substances Insulin-Like Growth Factor Binding Protein 2 ; Triglycerides ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2023-06-07
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 603841-4
    ISSN 1522-1555 ; 0193-1849
    ISSN (online) 1522-1555
    ISSN 0193-1849
    DOI 10.1152/ajpendo.00108.2023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Plasma IGFBP-2 levels reveal heterogeneity in hepatic fat content in adults with excess visceral adiposity.

    Rauzier, Chloé / Chartrand, Dominic J / Alméras, Natalie / Lemieux, Isabelle / Larose, Eric / Mathieu, Patrick / Pibarot, Philippe / Lamarche, Benoît / Rhéaume, Caroline / Poirier, Paul / Després, Jean-Pierre / Picard, Frédéric

    Frontiers in endocrinology

    2023  Volume 14, Page(s) 1222101

    Abstract: Lay summary: Obesity is frequently accompanied by a fatty liver. However, some individuals with high abdominal fat levels nevertheless have low levels of liver fat. Reasons for such discordant phenotypes are unclear. In this paper, we report that among ... ...

    Abstract Lay summary: Obesity is frequently accompanied by a fatty liver. However, some individuals with high abdominal fat levels nevertheless have low levels of liver fat. Reasons for such discordant phenotypes are unclear. In this paper, we report that among asymptomatic individuals with high levels of visceral fat, low concentrations of IGFBP-2 in the circulation were associated with significantly higher hepatic fat content compared to those with high IGFBP-2 levels. We conclude that quantification of plasma IGFBP-2 concentrations may be useful to identify the early risk for liver fat accumulation in apparently healthy individuals without cardiovascular symptoms.
    Aim/hypothesis: Although excess visceral adiposity (VAT) is generally associated with increased liver fat (LF), recent evidence has revealed heterogeneity in LF content among adults with visceral obesity, potentially contributing to specific differences in cardiometabolic outcomes. Reasons for such discordant VAT-LF phenotypes are largely unknown. The present study aimed at assessing whether circulating levels of insulin growth-factor binding protein-2 (IGFBP-2) could be a useful biomarker in the identification of heterogenous and discordant VAT-LF phenotypes.
    Methods: A sample of 308 middle-aged Caucasian apparently healthy men and women without cardiovascular symptoms were studied for the present cross-sectional analyses. Fasting plasma glucose and lipid levels were assessed and an oral glucose tolerance test was performed. Hepatic fat fraction (HFF) was measured using magnetic resonance spectroscopy whereas VAT was assessed by magnetic resonance imaging. Plasma IGFBP-2 levels were quantified by ELISA. Participants were then classified on the basis of median VAT (81 mL) and IGFBP-2 levels (233 ng/mL).
    Results: Individuals with high levels of VAT were characterized by higher waist circumference, lower insulin sensitivity, as well as by higher plasma triglyceride and lower HDL-cholesterol levels. Plasma IGFBP-2 levels were inversely correlated with HFF (r = -0.39,
    Conclusion: In the presence of excess VAT, high IGFBP-2 concentrations are associated with low levels of LF. Although additional studies will be necessary to establish causality and further clarify the clinical implications of these observations, these findings are concordant with a novel function of IGFBP-2 in modulating susceptibility to non-alcoholic fatty liver disease (NAFLD) in the presence of visceral obesity.
    MeSH term(s) Adult ; Female ; Humans ; Male ; Middle Aged ; Adiposity/genetics ; Adiposity/physiology ; Cross-Sectional Studies ; Heart Diseases ; Insulin/metabolism ; Insulin-Like Growth Factor Binding Protein 2/blood ; Insulin-Like Growth Factor Binding Protein 2/genetics ; Insulin-Like Growth Factor Binding Protein 2/metabolism ; Intra-Abdominal Fat/metabolism ; Liver/metabolism ; Liver/pathology ; Non-alcoholic Fatty Liver Disease ; Obesity/metabolism ; Obesity, Abdominal/blood ; Obesity, Abdominal/metabolism
    Chemical Substances Insulin ; Insulin-Like Growth Factor Binding Protein 2
    Language English
    Publishing date 2023-10-04
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2023.1222101
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Synthetic Methodologies to Gold Nanoshells: An Overview.

    Wang, Yu-Chen / Rhéaume, Éric / Lesage, Frédéric / Kakkar, Ashok

    Molecules (Basel, Switzerland)

    2018  Volume 23, Issue 11

    Abstract: Gold nanostructures that can be synthetically articulated to adapt diverse morphologies, offer a versatile platform and tunable properties for applications in a variety of areas, including biomedicine and diagnostics. Among several conformational ... ...

    Abstract Gold nanostructures that can be synthetically articulated to adapt diverse morphologies, offer a versatile platform and tunable properties for applications in a variety of areas, including biomedicine and diagnostics. Among several conformational architectures, gold nanoshells provide a highly advantageous combination of properties that can be fine-tuned in designing single or multi-purpose nanomaterials, especially for applications in biology. One of the important parameters for evaluating the efficacy of gold nano-architectures is their reproducible synthesis and surface functionalization with desired moieties. A variety of methods now exist that allow fabrication and chemical manipulation of their structure and resulting properties. This review article provides an overview and a discussion of synthetic methodologies to a diverse range of gold nanoshells, and a brief summary of surface functionalization and characterization methods employed to evaluate their overall composition.
    MeSH term(s) Chemical Phenomena ; Chemistry Techniques, Synthetic ; Gold/chemistry ; Metal Nanoparticles/chemistry ; Metal Nanoparticles/ultrastructure ; Nanoshells/chemistry ; Nanoshells/ultrastructure ; Particle Size ; Spectrum Analysis ; Surface Plasmon Resonance
    Chemical Substances Gold (7440-57-5)
    Language English
    Publishing date 2018-11-02
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 1413402-0
    ISSN 1420-3049 ; 1431-5165 ; 1420-3049
    ISSN (online) 1420-3049
    ISSN 1431-5165 ; 1420-3049
    DOI 10.3390/molecules23112851
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans.

    Brodeur, Mathieu R / Rhainds, David / Charpentier, Daniel / Boulé, Marie / Mihalache-Avram, Téodora / Mecteau, Mélanie / Brand, Geneviève / Pedneault-Gagnon, Valérie / Fortier, Annik / Niesor, Eric J / Rhéaume, Eric / Maugeais, Cyrille / Tardif, Jean-Claude

    Journal of lipid research

    2022  Volume 64, Issue 1, Page(s) 100316

    Abstract: The large HDL particles generated by administration of cholesteryl ester transfer protein inhibitors (CETPi) remain poorly characterized, despite their potential importance in the routing of cholesterol to the liver for excretion, which is the last step ... ...

    Abstract The large HDL particles generated by administration of cholesteryl ester transfer protein inhibitors (CETPi) remain poorly characterized, despite their potential importance in the routing of cholesterol to the liver for excretion, which is the last step of the reverse cholesterol transport. Thus, the effects of the CETPi dalcetrapib and anacetrapib on HDL particle composition were studied in rabbits and humans. The association of rabbit HDL to the LDL receptor (LDLr) in vitro was also evaluated. New Zealand White rabbits receiving atorvastatin were treated with dalcetrapib or anacetrapib. A subset of patients from the dal-PLAQUE-2 study treated with dalcetrapib or placebo were also studied. In rabbits, dalcetrapib and anacetrapib increased HDL-C by more than 58% (P < 0.01) and in turn raised large apo E-containing HDL by 66% (P < 0.001) and 59% (P < 0.01), respectively. Additionally, HDL from CETPi-treated rabbits competed with human LDL for binding to the LDLr on HepG2 cells more than control HDL (P < 0.01). In humans, dalcetrapib increased concentrations of large HDL particles (+69%, P < 0.001) and apo B-depleted plasma apo E (+24%, P < 0.001), leading to the formation of apo E-containing HDL (+47%, P < 0.001) devoid of apo A-I. Overall, in rabbits and humans, CETPi increased large apo E-containing HDL particle concentration, which can interact with hepatic LDLr. The catabolism of these particles may depend on an adequate level of LDLr to contribute to reverse cholesterol transport.
    MeSH term(s) Humans ; Rabbits ; Animals ; Anticholesteremic Agents/pharmacology ; Anticholesteremic Agents/therapeutic use ; Cholesterol/metabolism ; Apolipoproteins E/metabolism ; Cholesterol Ester Transfer Proteins/metabolism ; Cholesterol, HDL
    Chemical Substances apolipoprotein E-rich HDL ; dalcetrapib (3D050LIQ3H) ; anacetrapib (P7T269PR6S) ; Anticholesteremic Agents ; Cholesterol (97C5T2UQ7J) ; Apolipoproteins E ; Cholesterol Ester Transfer Proteins ; Cholesterol, HDL
    Language English
    Publishing date 2022-11-19
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80154-9
    ISSN 1539-7262 ; 0022-2275
    ISSN (online) 1539-7262
    ISSN 0022-2275
    DOI 10.1016/j.jlr.2022.100316
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top